TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 335 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2019. The put-call ratio across all filers is 1.03 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $329 | +5.4% | 20,000 | 0.0% | 0.38% | -13.5% |
| Q4 2022 | $312 | -99.9% | 20,000 | -55.6% | 0.44% | +7.9% |
| Q3 2022 | $583,000 | -74.8% | 45,000 | -73.5% | 0.40% | -67.4% |
| Q4 2021 | $2,310,000 | -51.5% | 169,500 | -41.7% | 1.24% | -44.0% |
| Q3 2021 | $4,762,000 | +71.9% | 290,753 | +76.6% | 2.21% | +99.8% |
| Q2 2021 | $2,770,000 | +47.3% | 164,610 | +59.8% | 1.11% | +57.8% |
| Q1 2021 | $1,880,000 | +105.9% | 102,988 | +101.1% | 0.70% | +81.6% |
| Q3 2020 | $913,000 | +234.4% | 51,200 | +184.4% | 0.39% | +85.6% |
| Q1 2020 | $273,000 | – | 18,000 | +1799900.0% | 0.21% | – |
| Q3 2019 | $0 | -100.0% | 1 | -100.0% | 0.00% | -100.0% |
| Q2 2019 | $38,000 | -97.8% | 2,200 | -97.4% | 0.01% | -98.1% |
| Q1 2019 | $1,714,000 | +171300.0% | 84,146 | +140143.3% | 0.59% | – |
| Q4 2018 | $1,000 | -100.0% | 60 | -100.0% | 0.00% | -100.0% |
| Q3 2018 | $3,123,000 | +66.9% | 146,156 | +63.1% | 0.73% | -2.0% |
| Q2 2018 | $1,871,000 | – | 89,600 | – | 0.74% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Adelphi Capital LLP | 8,958,784 | $176,757,000 | 33.75% |
| Ovata Capital Management Ltd | 879,800 | $17,557,092,000 | 13.04% |
| Paulson & Co. | 13,244,711 | $261,318,000 | 5.64% |
| Glenview Capital Management | 30,582,721 | $603,397,000 | 5.28% |
| MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC | 718,028 | $14,167,000 | 4.85% |
| Velanne Asset Management Ltd | 302,694 | $5,972,000 | 3.52% |
| Blackcrane Capital, LLC | 172,708 | $3,408,000 | 2.72% |
| Melqart Asset Management (UK) Ltd | 1,557,000 | $30,720,000 | 2.57% |
| GMT CAPITAL CORP | 3,345,976 | $66,016,000 | 2.55% |
| REDWOOD CAPITAL MANAGEMENT, LLC | 827,955 | $16,336,000 | 2.24% |